FDA Adverse Event Malfunction Summary report: N

ENDOTAK RELIANCE

MDR report key: 3053128 · Received April 11, 2013

Report

Report Number
2124215-2013-04337
Event Type
Malfunction
Date Received
April 11, 2013
Date of Event
March 11, 2013
Report Date
May 8, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. RESISTANCE AND PRESSURE TESTS WERE COMPLETED TO ASSESS LEAD ELECTRICAL PERFORMANCE AND INSULATION INTEGRITY. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. MICROSCOPIC INSPECTIONS OF THE TERMINAL PIN ASSEMBLY, LEAD BODY, AND ELECTRODE TIP FOUND NO ANOMALIES. LABORATORY TESTING WAS UNABLE TO REPRODUCE THE REPORTED CLINICAL OBSERVATIONS AND DETAILED ANALYSIS DID NOT REVEAL ANY ABNORMALITIES.

Additional Manufacturer Narrative · 1

THE LEAD WAS REMOVED AND RETURNED FOR ANALYSIS. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A RECENT IMPLANT PROCEDURE THIS RIGHT VENTRICULAR (RV) LEAD REVEALED A LOSS OF CAPTURE (LOC) DURING PRODUCT TESTING. THE LEAD WAS REMOVED AND REPLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE PROCEDURE WAS SUCCESSFULLY COMPLETED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
155180 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0175

Patients

Seq Age Sex Outcome Treatment
1